Sector consensus Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 23/01/2026 am IST			5-day change	1st Jan Change
755.51 ^USD	+0.82%		+1.83%	-2.12%

22/01	Evercore ISI Adjusts Price Target on Regeneron Pharmaceuticals to $875 From $750, Maintains Outperform Rating	MT
21/01	Ocular Therapeutix, Inc. Appoints David W. Robinson As Global Chief Commercial Officer	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
REGENERON PHARMACEUTICALS, INC.			$830.04	+9.86%	26
SAMSUNG BIOLOGICS CO.,LTD.			₩22,50,034.99	+26.55%	26
CSL LIMITED			A$157.23	+28.94%	16
UCB			€264.21	+2.05%	19
BIOGEN INC.			$190.93	+9.86%	29
INCYTE CORPORATION			$102.33	-2.6%	21
MODERNA, INC.			$37.4	-27.9%	20
INNOVENT BIOLOGICS, INC.			HK$100.3	+37.51%	25
BRIDGEBIO PHARMA, INC.			$89.79	+12.36%	19
INTRA-CELLULAR THERAPIES, INC.	-	-	-	-	-
ALTEOGEN INC.			₩4,82,500	+30.41%	4
SWEDISH ORPHAN BIOVITRUM AB			SEK 372.42	+11.77%	12
AVIDITY BIOSCIENCES, INC.			$74.64	+2.61%	11
BIOMARIN PHARMACEUTICAL INC.			$90.74	+58.69%	23
AXSOME THERAPEUTICS, INC.			$210.19	+12.41%	20
KRYSTAL BIOTECH, INC.			$276.6	-4.33%	10
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	CN¥50	+13.82%	1
3SBIO INC.			HK$34.81	+62.48%	11
GRIFOLS, S.A.			€15.08	+38.43%	12
Average			1,51,968.43	+17.94%	17
Weighted average by Cap.			3,02,739.74	+15.43%	20